Anirban Maitra· @Aiims1742 · X·· 2026-04-20Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
zoldonrasib and VS-7375 in G12D remain Phase 1 — strong numbers, small samples, not head-to-head.
Body
Zoldonrasib Deemed Safe, Effective in KRAS G12D-mutant #LungCancer
https://
aacrjournals.org/cancerdiscover
y/article/doi/10.1158/2159-8290.CD-NW2026-0040/783796/Zoldonrasib-Deemed-Safe-Effective-in-KRASG12D
…
#AACR26
@CD_AACR
Heat 64 · 48 likes · 4 replies · 12 reposts
Source: Anirban Maitra · x.com